Chief Business Officer
Pascal was appointed the Company's Chief Business Officer in 2010.
Prior to that, he was Vice-President Business Development since March 2005.
has spent over 15 years in the biotechnology and pharmaceutical industries, covering R&D, Management and Business Development positions on the West Coast (USA) and in Switzerland.
Previously, he was the Director of Business Development at Phyllom (2003), and a part of Maxygen's successful IPO.
At Maxygen, he
was in charge of two corporate alliances and promotion of its gene shuffling platform technology to third parties.
At Phistem, Maxygen and Phyllom, Pascal was responsible for corporate development, strategic alliances, in- and out-licensing, leading international research collaboration and US government contract with the Department of Defense.
He has a PhD in Genetics and Microbiology from the University of Lausanne, followed by postdoctoral research at UC Berkeley in Molecular Biology and at Lawrence Berkeley National Laboratory in Biodefence.
He has an MBA from HEC Business School, Lausanne.